On July 12, 2018, Beijing Huaxia Shunze Investment Group Co., Ltd. (HXSZ Investment) concluded an all-round strategic cooperation agreement with Guang'anmen Hospital, China Academy of Chinese Medical Sciences (CACMS).
Founded in 1955, CACMS Guang'anmen Hospital is a top-grade TCM hospital engaged in medical treatment, teaching, research, prevention and healthcare directly under the State Administration of Traditional Chinese Medicine, a healthcare base for central cadres, as well as a national model TCM hospital. With rich hospital management experience and TCM industry resources, it has persistently promoted the medical legacy of China, focused on TCM therapies including Chinese herb, acupuncture, massage and rehabilitation training, and employed modern means of diagnosis and treatment in TCM therapies. It has accumulated rich and unique experience in treating common diseases, miscellaneous diseases and other diseases, and achieved significant results in scientific research, characteristic preparations, team building, international exchanges and cooperation, training and education, and other fields.
In association with CACMS Guang'anmen Hospital, as well as other domestic top TCM research and education institutions, HXSZ Investment will focus on TCM and relevant industrial fields, develop the medical and great health industry including TCM treatment, TCM products, health management, TCM-based health preservation and third-party service, center on Haidian TCM Clinic, drive the group's industries and property health sector, respond to the national strategy of "Healthy China", and contribute to the development of China's medical health cause in the new era.